Clinical impact of admission urinary 8-hydroxydeoxyguanosine level for predicting cardiovascular mortality in patients with acute coronary syndrome.

MLA

Gohbara, Masaomi, et al. “Clinical Impact of Admission Urinary 8-Hydroxydeoxyguanosine Level for Predicting Cardiovascular Mortality in Patients with Acute Coronary Syndrome.” Heart & Vessels, vol. 36, no. 1, Jan. 2021, pp. 38–47. EBSCOhost, https://doi.org/10.1007/s00380-020-01663-4.

APA

Gohbara, M., Iwahashi, N., Nakahashi, H., Kataoka, S., Takahashi, H., Kirigaya, J., Minamimoto, Y., Akiyama, E., Okada, K., Matsuzawa, Y., Konishi, M., Maejima, N., Hibi, K., Kosuge, M., Ebina, T., Sugano, T., Ishikawa, T., Tamura, K., & Kimura, K. (2021). Clinical impact of admission urinary 8-hydroxydeoxyguanosine level for predicting cardiovascular mortality in patients with acute coronary syndrome. Heart & Vessels, 36(1), 38–47. https://doi.org/10.1007/s00380-020-01663-4

Chicago

Gohbara, Masaomi, Noriaki Iwahashi, Hidefumi Nakahashi, Shunsuke Kataoka, Hironori Takahashi, Jin Kirigaya, Yugo Minamimoto, et al. 2021. “Clinical Impact of Admission Urinary 8-Hydroxydeoxyguanosine Level for Predicting Cardiovascular Mortality in Patients with Acute Coronary Syndrome.” Heart & Vessels 36 (1): 38–47. doi:10.1007/s00380-020-01663-4.